-
Idorsia is a
Swiss pharmaceutical research company in Allschwil, near Basel, Switzerland.
After Actelion was
bought by
Johnson &
Johnson in 2017, Idorsia...
-
endothelin B receptors. It is
developed for
resistant hypertension by
Idorsia,
which sold it to
Janssen but
purchased the
rights back in 2023 for $343...
- May 2022.
Retrieved 5 May 2022. "
Idorsia receives US FDA
approval of
Quviviq (daridorexant)" (Press release).
Idorsia Pharmaceuticals. 10
January 2022...
- the
extended Glascow Outcome Scale. "
Idorsia receives ****anese PMDA
approval of Pivlaz" (Press release).
Idorsia. 20
January 2022.
Retrieved 22 January...
- "Xbox
Series X –
Lucid Odyssey", Xbox (2020) "Seize the
Night & Day",
Idorsia (2022) "Belvedere
Presents Daniel Craig",
Belvedere Vodka (2022) "Joy Is...
- to
Phase III
clinical trials, but in its
financial results for Q1 2018,
Idorsia mentions that
Actelion informed them that "following
completion of Phase...
- (DORA)
drugs on the market:
Belsomra (Merck),
Dayvigo (Eisai) and
Quviviq (
Idorsia).
Certain atypical antipsychotics,
particularly quetiapine, olanzapine...
-
December 1955) is a scientist,
entrepreneur and co-founder of
Actelion and
Idorsia.
Clozel studied at the
University of
Nancy and the
University of California...
-
Dielsdorf NBE-Therapeutics:
Basel Santhera:
Basel AC Immune:
Lausanne Idorsia:
Allschwil VAXIMM:
Basel Cerbios-Pharma:
Lugano Finox Biotech: Kirchberg...
-
development unit
would also be spun off
after the acquisition. The new
company Idorsia was
created from
former Actelion drug
discovery operations and early-stage...
